**INTRODUCTION:** The objective of this study was to test the osteogenic capacity of dipyridamole-loaded, 3D-printed bioactive ceramic (3DPBC) scaffolds utilizing a translational, skeletally-mature, large animal calvarial defect model.

**METHODS:** Custom 3DPBC scaffolds designed to present lattice-based porosity only towards the dural surface were either coated with collagen (control) or coated with collagen and immersed in a 100 µM concentration dipyridamole (DIPY) solution. Sheep (n=5) were subjected to 2 ipsilateral trephine-induced (11 mm diameter) calvarial defects. Either a control or a DIPY scaffold was placed in each defect and the surgery was repeated on the contralateral side 3 weeks later. Following sacrifice, defects were evaluated through microcomputed tomography and histologic analysis for bone, scaffold, and soft tissue quantification throughout the defect. Parametric and non-parametric methods were utilized to determine statistical significance based on data distribution.

**RESULTS:** No exuberant or ectopic bone formation was observed and no histologic evidence of inflammation was noted within the defects. Osteogenesis was higher in DIPY-coated scaffolds compared to controls at 3 weeks (p=0.013) and 6 weeks (p=0.046) *in vivo*. When bone formation was evaluated as a function of defect radius, average bone formation was higher for DIPY relative to control scaffolds at both time points (significant at defect central regions at 3 weeks and at margins at 6 weeks; p=0.046 and p=0.031, respectively).

**CONCLUSION:** Dipyridamole significantly improves the calvarial bone regeneration capacity of 3D-printed bioactive ceramic scaffolds. The most significant difference in bone regeneration was observed centrally within the interface between the 3DPBC scaffold and the dura mater.
